Journal
VIROLOGY
Volume 394, Issue 2, Pages 175-182Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2009.09.024
Keywords
Dengue virus; Virus neutralization; Humanized monoclonal antibody; Fc receptor
Categories
Funding
- Pediatric Dengue Vaccine Initiative of the International Vaccine Institute [TR 03/04, TR16]
- NIH [R01 AI073755, U01AI77955]
Ask authors/readers for more resources
Severe dengue virus (DENV) infection is epidemiologically linked to pre-existing anti-DENY antibodies acquired by maternal transfer or primary infection. A possible explanation is that DENY immune complexes evade neutralization by engaging Fc gamma receptors (Fc gamma R) on monocytes, natural targets for DENV in humans. Using epitope-matched humanized monoclonal antibodies (mAbs) and stable Fc gamma R-transfected CV-1 cells, we found that DENY neutralization by IgG1, IgG3, and IgG4 mAbs was enhanced in high-affinity Fc gamma RIA transfectants and diminished in low-affinity Fc gamma RIIA transfectants, whereas neutralization by IgG2 mAbs (low-affinity ligands for both Fc gamma Rs) was diminished equally. In Fc gamma R-negative Vero cells, IgG3 mAbs exhibited the strongest neutralizing activity and IgG2, the weakest. Our results demonstrate that DENY neutralization is modulated by the Fc region in an IgG subclass manner, likely through effects on virion and Fc gamma R binding. Thus, the IgG antibody subclass profile generated by DENY infection or vaccination may independently influence the magnitude of the neutralizing response. (C) 2009 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available